Wells Fargo upgrades Editas Medicine to Overweight, targets $6
Wells Fargo upgraded Editas Medicine to Overweight and set a $6 price target, from an Equal Weight rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.